Patient-reported outcomes in vasculitis

被引:1
|
作者
Crawshaw, Helena [1 ]
Janagan, Shalini [2 ]
Austin, Keziah [2 ,3 ]
Baker, Charlotte [2 ]
Day, Julia [2 ]
Robson, Joanna C. [4 ]
机构
[1] Gloucestershire Royal Hosp NHS Trust, Rheumatol Dept, Great Western Rd, Gloucester GL1 3NN, England
[2] Univ Hosp Bristol & Weston NHS Fdn Trust, Rheumatol Dept, Bristol Royal Infirmary, Marlborough St, Bristol BS1 3NU, England
[3] Royal Natl Hosp Rheumat Dis, Rheumatol Dept, Combe Pk, Bath BA1 3NG, England
[4] Univ West England, Ctr Hlth & Clin Res, Bristol Royal Infirmary, Room 5-054,Rheumatol Res B502, Bristol BS2 8HW, England
来源
关键词
Patient-reported outcomes (PRO); Patient-reported outcome measures; (PROMs); Patient-reported experience measures; (PREMs); Systemic vasculitis; Giant cell arteritis (GCA); Takayasu's arteritis (TAK); IgA vasculitis; Behcet's disease; Urticarial vasculitis; ANCA-Associated vasculitis (AAVs); QUALITY-OF-LIFE; ANCA-ASSOCIATED VASCULITIS; PATIENTS PERSPECTIVE; BEHCETS-DISEASE; RHEUMATOID-ARTHRITIS; TAKAYASUS-ARTERITIS; HEALTH; VALIDATION; TRIALS; CARE;
D O I
10.1016/j.berh.2023.101829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic vasculitis encompasses a group of multisystem disorders; both the diseases and the treatment strategies can have a significant impact on a patient's health-related quality of life (HRQoL). Using patient-reported outcome measures (PROMs) and patientreported experience measures (PREMs) to evaluate the patient's view of their condition, treatments, and healthcare journey is essential to the patient-centered care approach. In this paper, we discuss the use of generic, disease-specific, and treatment-specific PROMs and PREMs in systemic vasculitis and future research goals. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] FACTORS INFLUENCING PATIENT-REPORTED OUTCOMES IN ANCA-ASSOCIATED VASCULITIS
    Monti, S.
    Delvino, P.
    Klersy, C.
    Coppa, G.
    Milanesi, A.
    Montecucco, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 668 - 669
  • [2] Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
    Cherrez-Ojeda, Ivan
    Vanegas, Emanuel
    Felix, Miguel
    Mata, Valeria L.
    Cherrez, Annia
    [J]. BMC DERMATOLOGY, 2018, 18
  • [3] Patient-reported outcomes
    Garratt, Andrew
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (07) : 668 - 668
  • [4] Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes
    Robson, Joanna C.
    Jayne, David
    Merkel, Peter A.
    Dawson, Jill
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 37 - 42
  • [5] Patient-reported outcomes Recording and evaluating patient-reported endpoints
    Hilser, Thomas
    Darr, Christopher
    Gruenwald, Viktor
    [J]. ONKOLOGIE, 2022, 28 (10): : 940 - 946
  • [6] DEVELOPMENT OF A PATIENT-REPORTED OUTCOME MEASURE FOR VASCULITIS
    Robson, Joanna
    [J]. RHEUMATOLOGY, 2017, 56 : 24 - 24
  • [7] Telemedizinische Erfassung von „patient-reported outcomes“Remote monitoring of patient-reported outcomes
    V. Siefert
    G. Welzel
    M. Blessing
    L. Jahnke
    J. Hesser
    F. Wenz
    F. A. Giordano
    [J]. Forum, 2018, 33 (2) : 94 - 100
  • [8] Patient-reported outcomes and patient voices
    Asci, Gulay
    Ok, Ercan
    [J]. SEMINARS IN DIALYSIS, 2022, 35 (05) : 457 - 458
  • [9] Patient copayments and patient-reported outcomes
    Mullins, CD
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (04) : 674 - 674
  • [10] Patient-Reported Outcomes (Pros) and Patient-Reported Outcome Measures (Proms)
    Weldring, Theresa
    Smith, Sheree M. S.
    [J]. HEALTH SERVICES INSIGHTS, 2013, 6 : 61 - 68